Publications, Pharmaceutical
Poor patient adherence is widespread but particularly problematic with respect to the control of respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). This article considers how connected devices can help. As the global incidence of respiratory disease rises poor adherence to prescribed medications is associated with both escalating healthcare costs and compromised quality of life. Connected devices are a cornerstone of the digital healthcare solutions that can help patients to understand how to use prescribed inhalers successfully, and at the same time enable more effective monitoring by health care practitioners. Aptar Pharma is working at the forefront of connect device development with a number of partners to realise this potential.
Sai Shankar details the problem of non-adherence, in particular in asthma and COPD, and how its solution, along with myriad other benefits, can be found in digital healthcare and connected devices.
“Around 50-60% of symptoms in asthma patients are uncontrolled and adherence rates to daily controller medications are under 30%. It is predicted that another 100 million people will suffer from asthma by 2025, so the need to better manage patient adherence will only accelerate…”
Submit your email address below and stay up to date with the latest industry insights.
*Required. For details about how your email address will be used, read our General Terms and Conditions of Use, Privacy and Cookies Policy.
Requesting access to Connected Health – An Effective Solution to Improve Patient Adherence.
